HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shigehiro Katayama Selected Research

18-hydroxydeoxycorticosterone

4/2002Preclinical Cushing's syndrome due to ACTH-independent bilateral macronodular adrenocortical hyperplasia with excessive secretion of 18-hydroxydeoxycorticosterone and corticosterone.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shigehiro Katayama Research Topics

Disease

23Type 2 Diabetes Mellitus (MODY)
11/2017 - 05/2002
10Hypertension (High Blood Pressure)
01/2018 - 04/2002
10Insulin Resistance
01/2012 - 05/2003
6Diabetic Nephropathies (Diabetic Nephropathy)
01/2018 - 01/2002
6Diabetes Mellitus
06/2009 - 01/2003
5Diabetic Retinopathy (Retinopathy, Diabetic)
01/2015 - 05/2002
5Atherosclerosis
01/2009 - 01/2003
4Type 1 Diabetes Mellitus (Autoimmune Diabetes)
03/2018 - 02/2002
4Hyperglycemia
11/2017 - 07/2006
4Albuminuria
04/2017 - 02/2006
4Body Weight (Weight, Body)
09/2015 - 07/2002
4Coronary Disease (Coronary Heart Disease)
05/2012 - 02/2010
4Dyslipidemias (Dyslipidemia)
02/2011 - 08/2009
4Metabolic Syndrome (Dysmetabolic Syndrome X)
02/2010 - 10/2005
3Diabetes Complications
02/2017 - 11/2011
3Obesity
01/2012 - 04/2005
3Macular Degeneration (Age-Related Maculopathy)
06/2011 - 11/2007
3Cardiovascular Diseases (Cardiovascular Disease)
03/2009 - 10/2005
3Graves Disease (Basedow Disease)
01/2009 - 08/2002
3Thyroiditis
01/2009 - 04/2003
3Glucose Intolerance
10/2008 - 07/2006
2Abdominal Obesity
03/2009 - 10/2005
2Hypertrophy
01/2007 - 01/2005
2Proteinuria
02/2006 - 01/2005
2Macular Edema
08/2005 - 09/2004
2Hyperplasia
04/2005 - 04/2002
2Neointima
02/2004 - 02/2003
1Hepatitis B
07/2019
1Adrenal Insufficiency (Adrenal Gland Hypofunction)
07/2019
1Rheumatic Diseases (Rheumatism)
07/2019
1Hyperkalemia
04/2017
1Adrenocortical Carcinoma
01/2016
1Hypersensitivity (Allergy)
01/2015
1Stroke (Strokes)
10/2014
1Weight Gain
07/2014

Drug/Important Bio-Agent (IBA)

8Glucose (Dextrose)FDA LinkGeneric
01/2018 - 12/2004
7Insulin (Novolin)FDA Link
05/2015 - 06/2004
7Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
11/2011 - 02/2002
6Pharmaceutical PreparationsIBA
11/2017 - 07/2006
6Angiotensin Receptor AntagonistsIBA
04/2012 - 02/2006
5LipidsIBA
05/2012 - 07/2003
5oxidized low density lipoproteinIBA
06/2010 - 07/2006
4olmesartanIBA
10/2015 - 03/2011
4Calcium Channel Blockers (Blockers, Calcium Channel)IBA
10/2015 - 06/2004
4Triglycerides (Triacylglycerol)IBA
11/2011 - 07/2006
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2011 - 05/2002
4AdiponectinIBA
01/2010 - 12/2004
3Dipeptidyl-Peptidase IV InhibitorsIBA
01/2018 - 10/2014
3Hypoglycemic Agents (Hypoglycemics)IBA
11/2017 - 06/2004
3Sitagliptin Phosphate (Januvia)FDA Link
03/2016 - 10/2014
3AlbuminsIBA
05/2013 - 01/2005
3HDL CholesterolIBA
05/2013 - 08/2009
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2010 - 03/2004
3LDL Lipoproteins (beta Lipoproteins)IBA
02/2010 - 07/2006
3PPAR gammaIBA
01/2010 - 12/2004
3Telmisartan (Micardis)FDA Link
01/2010 - 06/2007
3AcarboseFDA LinkGeneric
05/2009 - 07/2006
3glimepiride (Amarel)FDA LinkGeneric
03/2009 - 03/2005
3Proteins (Proteins, Gene)FDA Link
01/2009 - 04/2005
3Nitric Oxide (Nitrogen Monoxide)FDA Link
09/2004 - 02/2004
2Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
11/2017 - 03/2004
2mitiglinideIBA
03/2016 - 03/2009
2DiureticsIBA
10/2015 - 10/2014
2AntioxidantsIBA
01/2015 - 10/2012
2Untranslated RNA (Noncoding RNA)IBA
01/2015 - 01/2014
2Alkaline PhosphataseIBA
07/2013 - 05/2007
2CreatinineIBA
05/2013 - 06/2007
2EnzymesIBA
10/2012 - 07/2002
2Antihypertensive Agents (Antihypertensives)IBA
04/2012 - 08/2009
2LDL CholesterolIBA
11/2011 - 06/2010
2Fatty Acids (Saturated Fatty Acids)IBA
06/2011 - 07/2006
2Complement Factor H (Factor H)IBA
01/2011 - 11/2007
2pigment epithelium-derived factorIBA
01/2011 - 09/2007
2Lipoproteins (Lipoprotein)IBA
02/2010 - 01/2009
2AMP-Activated Protein KinasesIBA
11/2008 - 03/2005
2imidaprilIBA
07/2006 - 02/2002
2Biomarkers (Surrogate Marker)IBA
07/2006 - 01/2006
2CalciumIBA
04/2005 - 03/2004
2Collagen Type IV (Type IV Collagen)IBA
01/2005 - 01/2002
2Fibric Acids (Fibrates)IBA
06/2004 - 03/2004
2Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
01/2004 - 08/2002
1Immunosuppressive Agents (Immunosuppressants)IBA
07/2019
1Adrenal Cortex Hormones (Corticosteroids)IBA
07/2019
1Hepatitis B Surface Antigens (HBsAg)FDA Link
07/2019
1Programmed Cell Death 1 ReceptorIBA
03/2018
1Sodium-Glucose Transporter 2 InhibitorsIBA
01/2018
1Glucagon-Like Peptide-1 Receptor AgonistsIBA
01/2018
1PotassiumIBA
04/2017
1finerenoneIBA
04/2017
1Hemoglobins (Hemoglobin)IBA
02/2017
1LiraglutideFDA Link
09/2015
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
05/2015
1VildagliptinIBA
05/2015
1Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA
10/2014
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
07/2014
1Anti-Bacterial Agents (Antibiotics)IBA
12/2013

Therapy/Procedure

6Therapeutics
07/2019 - 10/2005
6Glycemic Control
10/2014 - 11/2002
1Drug Therapy (Chemotherapy)
11/2017
1Adrenalectomy
01/2016